First Business Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-877
Closed -$213K 180
2022
Q1
$213K Hold
877
0.02% 161
2021
Q4
$228K Hold
877
0.02% 159
2021
Q3
$231K Hold
877
0.03% 144
2021
Q2
$216K Buy
+877
New +$184K 0.03% 150
2019
Q4
Sell
-6,902
Closed -$933K 136
2019
Q3
$933K Hold
6,902
0.16% 34
2019
Q2
$842K Sell
6,902
-203
-3% -$22.5K 0.15% 38
2019
Q1
$739K Sell
7,105
-142
-2% -$14.7K 0.13% 44
2018
Q4
$825K Sell
7,247
-514
-7% -$55.1K 0.14% 45
2018
Q3
$895K Hold
7,761
0.14% 38
2018
Q2
$804K Sell
7,761
-103
-1% -$10.4K 0.14% 34
2018
Q1
$774K Sell
7,864
-236
-3% -$22.3K 0.14% 32
2017
Q4
$686K Buy
8,100
+1,643
+25% +$136K 0.13% 50
2017
Q3
$497K Buy
+6,457
New +$494K 0.1% 54

Other funds holding RMD

First Business Financial Services's RMD Position: Q2 2022 in Review

First Business Financial Services sold out of ResMed (RMD) in Q2 2022, closing a stake of 877 shares — an estimated $213K sold.

First Business Financial Services first reported a position in RMD in Q3 2017 and held it in 13 quarters. The position peaked at $933K in Q3 2019. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • First Business Financial Services reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • First Business Financial Services sold 877 ResMed shares in Q2 2022, an estimated $213K.
  • First Business Financial Services first reported a position in ResMed in Q3 2017 and held it in 13 quarters.
  • First Business Financial Services's ResMed position peaked at $933K in Q3 2019.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on First Business Financial Services's 13F filing for Q2 2022, filed 2 Aug 2022.